Biography & Early Wealth Journey

Drew Angerer/Getty Images

For what it's worth, Purdue Pharma and the Sackler family have denied the allegations in the myriad lawsuits against them.

During the meeting with state attorney generals in Cleveland, Purdue's attorneys presented a plan for the company to declare Chapter 11 bankruptcy and then restructure into a for-profit "public benefit trust." This would include more than $4 billion in drugs made available to cities, counties and states. Some of the drugs are used to save people from overdoses. These in-kind drugs, plus the profits from the sale of the drugs, would lead to a total settlement for Purdue in the $7 billion to $8 billion range. The trust would be in place for at least 10 years. The Sackler family would be responsible for coming up with the remaining $3 billion to $4 billion by selling their shares in a company called Mundipharma. They would also be required to give up all ownership of Purdue and would not be appointed to the board of the trust.

Primary Income Streams & Multi-Million Contracts

Additionally, any profits from the sale of Purdue's drugs including OxyContin and Nalmefene – a drug that the FDA has fast tracked for its use as emergency treatment of opioid overdoses – would be divided among the cities, counties, and states that have brought the lawsuits against Purdue and the Sacklers, if they agree to the settlement.